Tilmacoxib是一种高选择性、时间依赖性且不可逆的COX-2抑制剂。

/

-25~-15℃避光保存，有效期3年。

[1] Wakitani K, Nanayama T, Masaki M, Matsushita M. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. Jpn J Pharmacol. 1998 Nov;78(3):365-71. doi: 10.1254/jjp.78.365. PMID: 9869271.[2]Hirose M, Miwa H, Kobayashi O, Oshida K, Misawa H, Kurosawa A, Watanabe S, Sato N. Inhibition of proliferation of gastric epithelial cells by a cyclooxygenase 2 inhibitor, JTE522, is also mediated by a PGE2-independent pathway. Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:83-9. doi: 10.1046/j.1365-2036.16.s2.28.x. PMID: 11966528.[3]Wei M, Morimura K, Wanibuchi H, Shen J, Doi K, Mitsuhashi M, Moku M, Salim EI, Fukushima S. Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. Cancer Lett. 2003 Dec 8;202(1):11-6. doi: 10.1016/s0304-3835(03)00477-4. PMID: 14643021.